CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-31 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right to Buy) | +110,305 | 110,305 | ||
| 2022-03-01 | Sandford Nicole President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2021-06-24 | LAFRANCE JAMES T Director | Grant or award | +330 | 423,192 | ||
| 2021-06-24 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right To Buy) | +502 | 502 | ||
| 2021-05-06 | LAFRANCE JAMES T Director | Grant or award | +423 | 422,862 | ||
| 2021-05-06 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right To Buy) | +720 | 720 | ||
| 2021-03-19 | Sandford Nicole Director | Grant or award | +15,902 | 32,402 | ||
| 2021-03-19 | Brooks Sandra Elaine Director | Grant or award | +14,728 | 14,728 | ||
| 2021-03-19 | Beechey Robert Harry Chief Financial Officer | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +150,000 | 150,000 | ||
| 2021-03-19 | Palmieri Valerie Barber President and CEO | Grant or award · EMPLOYEE STOCK OPTION (RIGHT TO BUY) | +450,000 | 450,000 | ||
| 2021-03-19 | Jordan Veronica GH Director | Grant or award | +16,442 | 287,519 | ||
| 2021-03-19 | SCHREIBER DAVID Director | Grant or award | +4,031 | 171,521 | ||
| 2021-03-19 | COCOZZA NANCY G Director | Grant or award | +15,680 | 128,632 | ||
| 2021-03-19 | LAFRANCE JAMES T Director | Grant or award | +9,205 | 422,439 | ||
| 2021-03-19 | LAFRANCE JAMES T Director | Grant or award · Employee Stock Option (Right to Buy) | +15,412 | 15,412 | ||
| 2020-09-08 | SCHREIBER DAVID Director | Sale | −50,000 | $2.78 | $139K | 185,018 |
| 2020-07-01 | SCHULER JACK W 10% owner | Purchase | +2,285,715 | $3.50 | $8.0M | 25,394,517 |
| 2020-06-09 | SCHULER JACK W 10% owner | Option exercise | +730,560 | $1.80 | $1.3M | 23,108,802 |
| 2020-06-09 | SCHULER JACK W 10% owner | Option exercise · Warrants (Right to buy) | −730,560 | 0 | ||
| 2020-06-08 | FEINBERG LARRY N 10% owner | Option exercise | +463,298 | $1.80 | $834K | 6,137,052 |
Page 12 of 15 · 296 trades